Login / Signup

Intracellular activity and in vivo efficacy in a mouse model of septic arthritis of the novel pseudopeptide Pep16 against Staphylococcus aureus clinical isolates.

Jean-Baptiste MascaryValérie BordeauIrène NicolasMarie-Clémence VerdierPierre RocheteauVincent Cattoir
Published in: JAC-antimicrobial resistance (2024)
, particularly owing to its robust intracellular activity.
Keyphrases
  • staphylococcus aureus
  • mouse model
  • rheumatoid arthritis
  • reactive oxygen species
  • acute kidney injury
  • escherichia coli
  • biofilm formation
  • candida albicans